Enzo Biochem Inc
![Enzo Biochem Inc](https://api.admiralmarkets.com/trade_icons/bright-128/ENZ.png)
Closed
Sector Healthcare
1.09 -0.91
Overview
Share price change
24h
Min
1.08
Max
1.1
Sales | 747K 8.6M |
---|---|
EPS | -0.061 |
Next Earnings | 31 Oct 2024 |
---|
Market Cap | -2.6M 61M |
---|---|
Previous open | 2 |
Previous close | 1.09 |
News Sentiment
By Acuity
50%
50%
114 / 365 Healthcare
Technical Score
By Trading Central
Confidence
Bullish Evidence
Enzo Biochem Inc Chart
Related News
Peer Comparison
Price change
Enzo Biochem Inc Forecast
Sentiment
By Acuity
114 / 365 Healthcare
News Sentiment
Neutral
Volatility
Below average
News Volume (RCV)
Below average
Financials
Selling and administration expenses
Operating expenses
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$
About Enzo Biochem Inc
Enzo Biochem, Inc. (Enzo) is an integrated diagnostics, clinical lab, and life sciences company that is focused on delivering and applying advanced technology to produce reliable products and services for clinical needs. The Company develops, manufactures and sells technology solutions and platforms to clinical laboratories, specialty clinics, researchers and physicians globally. Enzo's segments include Enzo Clinical Lab, Enzo Life Sciences and Enzo Therapeutics. Enzo Clinical Lab is a clinical reference laboratory providing a range of clinical services to physicians, medical centers, other clinical labs and pharmaceutical companies. Enzo Life Sciences manufactures, develops and markets products and tools for clinical research, drug development and bioscience research customers worldwide. Enzo Therapeutics is a biopharmaceutical venture that developed multiple novel approaches in the areas of gastrointestinal, infectious, ophthalmic and metabolic diseases.